CLINICAL_TRIALS
trial_result
· 2020-11-20
Clinical Trial Update: An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis [Phase 2]
Summary
Phase 2 trial of BG00011 in idiopathic pulmonary fibrosis was terminated with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: TERMINATED | Results posted: 2020-11-20